Does $24.6 Billion in Debt Make Bausch Health Companies Too Risky a Buy? [The Motley Fool]
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: The Motley Fool
Pharmaceutical providerBausch Health Companies(NYSE:BHCImage source: Getty Images.What seems to be the problem?Normally, pharmaceutical companies must commit a large portion of their revenues to research and development. This is because patents covering new drug discoveries last 0 years after the initial date of filing. After that date, branded drugs will see nearly all of their revenues eroded as authorized generic products begin flooding the market to bring down prices and make prescription drugs more affordable.Hence, branded-drug companies need to allocate massive amounts of capital to conducting clinical trials and bringing new drugs to market in order to protect their competitive moats. With regard to this metric, Bausch Health is performing poorly.Last year, the company's spending on research and development amounted to just $7 million, or .%, out of its $8.9 billion in revenues. Meanwhile, competitors in the sector spend an average of 0% to % on R&D.Usually, in cases such as t
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Bausch Health sets 2025 outlook at the higher end of the prior range [Seeking Alpha]Seeking Alpha
- Bausch Health Cos (NYSE:BHC) was given a new $8.00 price target on by analysts at Truist Financial Corporation.MarketBeat
- Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare ConferencePR Newswire
- 2 Strong Mid-Cap Growth Stocks Dan Loeb Bought in Q3 [Yahoo! Finance]Yahoo! Finance
BHC
Earnings
- 10/29/25 - Miss
BHC
Sec Filings
- 1/13/26 - Form 8-K
- 1/2/26 - Form 8-K
- 1/2/26 - Form 4
- BHC's page on the SEC website